PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY

This study is testing whether a vitamin B12 supplement called mecobalamin can prevent or reduce nerve damage (numbness, tingling, pain) that often occurs in the hands and feet during taxane chemotherapy. About 326 cancer patients will be randomly assigned to take the supplement o…

This small pilot study is testing whether a special spinal cord stimulator can help people with severe nerve pain caused by chemotherapy. The device is designed to automatically adjust its electrical pulses to help control pain, reduce medication use, and improve walking. Researc…

This pilot study is testing whether helping patients identify what matters most to them can improve management of chemotherapy-induced nerve pain. The trial involves 45 adult cancer survivors who experience significant nerve pain from past chemotherapy. Researchers will evaluate …

This early-stage study is exploring whether taking CBD capsules can help prevent nerve damage (neuropathy) caused by a common chemotherapy drug called oxaliplatin. The trial will involve 30 people with colorectal cancer who are scheduled to receive oxaliplatin treatment. Particip…

This study is testing whether a 12-week virtual Tai Chi program is a practical and acceptable way to help cancer survivors manage nerve pain and balance problems caused by chemotherapy. About 21 participants with these symptoms will be randomly assigned to either start the Tai Ch…

This small, early-stage study is testing whether a patch containing capsaicin (the compound that makes chili peppers hot) can help relieve pain and improve walking in people with nerve damage caused by chemotherapy. Researchers will measure changes in pain levels, walking speed, …

This study is testing whether a wearable device called Walkasins can help older adults with nerve damage in their feet (peripheral neuropathy) improve their balance and walking. Researchers will compare 200 participants who use the device daily for six months to a group that does…

This study aims to understand why people with nerve damage (peripheral neuropathy) from cancer treatment have a higher risk of falling and a lower quality of life. Researchers will compare 40 people with this nerve damage to a similar group without it, testing their balance, walk…